• Genoa in the News

Genoa Healthcare® featured in Chain Drug Review’s 2022 Industry Outlook

Jan 21st, 2022

Genoa Healthcare Chief Executive Officer Joe Douglas provides outlook for 2022

2022 will be another important year for the behavioral health community. The increase in mental illness and substance use disorder, along with the staffing challenges and shift to telehealth that we saw in 2021, will continue to impact the health care industry. Our pharmacy teams are prepared to step up with additional services that meet the changing needs of our partners and consumers.

Genoa Healthcare Chief Executive Officer Joe Douglas takes a look at the opportunities for expanded access to care in 2022 and provides an industry outlook in Chain Drug Review’s 2022 forecast. You can read the full article here or view it in Chain Drug Review’s recent issue.

Recent Posts


  • Blog Post
In-house, pharmacy management partnership or outsource? Questions to ask before choosing an on-site pharmacy model

Want to compare your options quickly? Download this overview. You’ve probably heard the benefits of adding a pharmacist to your care team. On-site pharmacies help break down barriers to care,...

  • Blog Post
340B made easy: 5 traits to look for in a contract pharmacy partner

The 340B Drug Pricing Program helps participating organizations – or covered entities – use savings on prescription drug costs to offer more comprehensive services and care for more eligible patients....

  • Blog Post
340B 101: What your clinic needs to know

For qualified clinics and organizations, the 340B Drug Pricing Program offers savings on prescription drug costs, helping boost offerings and outcomes for people who need it most. Wondering if your...

  • Blog Post
  • Webinar
The 340B Program information you’re looking for

For qualified clinics and organizations, the 340B Drug Pricing Program offers savings on prescription drug costs, helping boost offerings and outcomes for people who need it most. Wondering if your...